Sourced from:Manufacturer Authorized Distributor
Quick Summary
Rahika 200mg Tablet
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹14625
MRP: ₹15454.6
(You Save ₹829.6)
12 TABLET(s) IN A STRIP
Rahika 200 mg Tablet is a prescription anticancer medicine used in the treatment of hormone receptor–positive, HER2-negative breast cancer. It contains ribociclib, a targeted therapy that works by inhibiting cyclin-dependent kinases (CDK4/6), thereby slowing the growth and division of cancer cells. Rahika is used under strict oncologist supervision, usually as part of a combination treatment plan for advanced or metastatic breast cancer.
Sourced from:Manufacturer Authorized Distributor
5% OFF
₹14625
MRP: ₹15,454.60
Inclusive of all taxes
5% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Introduction
Rahika 200mg tablet contains the active ingredient Capmatinib. It is an anti-cancer medicine that belongs to the class of medications called protein kinase inhibitors. It is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other body parts or is caused by a change (mutation) in a gene that makes an enzyme called MET in adults.
Do not take this medicine if you are allergic to Rahika 200mg tablet or any ingredients. Inform the physician if you have or have ever had lung or breathing problems other than your lung cancer, liver problems, or pancreatic problems. Inform your physician if you have any symptoms of an allergic reaction, including rash, hives, fever, difficulty breathing, or low blood pressure. This medicine is not recommended for children and adolescents below 18 years of age.
Avoid getting pregnant and breastfeeding during the treatment. Use effective contraception to avoid pregnancy. The common side effects of Rahika 200mg tablet are swelling in the face, and body, nausea, tiredness, vomiting, shortness of breath, and decreased appetite. Rahika 200 mg tablet price India varies by retailer and location. Rahika tablet substitution with other brands containing the same active ingredient(s), but only under your doctor’s guidance.
Uses
Rahika 200 mg tablet uses are:
- Non-small cell lung cancer (NSCLC)
How Rahika 200mg Tablet Works
Rahika 200mg tablet is a kinase inhibitor that targets mesenchymal-epithelial transition (MET). It works by blocking the action of this abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
Interaction of Rahika 200mg Tablet with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, vaccinations, nutritional and vitamin supplements, and herbal products. Rahika 200 mg tablet interactions with certain medicines and reduce its effectiveness by causing undesirable side effects.
Storage Conditions
Rahika 200 mg tablet storage conditions are:
- Store at 20°C to 25°C
- Protect the medicine from light and excessive moisture.
- Keep the medicine out of reach of children and pets
- If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
How to take Rahika 200mg Tablet
It is an orally available prescription drug. Your doctor will decide the Rahika 200 mg dosage and duration of Rahika 200mg tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water.
Safety Advice for Rahika 200mg Tablet
Breast Feeding
Breastfeeding is not recommended in patients taking Rahika 200mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Alcohol
It is unknown whether it is safe to consume alcohol with Rahika 200mg tablet. Please consult your doctor.
Liver
Rahika 200mg tablet should be used cautiously in patients with liver problems. Dose adjustments are necessary for liver failure patients. Inform your physician if you have any liver diseases before initiating the therapy.
Lungs
Rahika 200mg tablet should be cautiously administered in patients with lung problems other than lung cancer. Inform your physician if you have any lung diseases before initiating the therapy.
Driving
It is unknown whether Rahika 200mg tablet alters the ability to drive or operate heavy machinery. If you feel dizzy or sleepy, avoid driving and consult your doctor.
Pregnancy
Do not take Rahika 200mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 7 days after your last dose.
Side Effects
Rahika 200 mg tablet side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Common
- Swelling in the face, and body
- Decrease in appetite
- Nausea
- Cough
- Fatigue
Serious
- Vomiting
- Liver injury
- Muscle pain
- Shortness of breath
- Lung infection
- Respiratory disease
Expert tips
-
Sun protection – Avoid direct sunlight or artificial UV light while on this medicine. Use sunscreen, sunglasses, and protective clothing outdoors, and continue these precautions for at least 7 days after your last dose.
-
Report abdominal pain – Contact your doctor right away if you experience abdominal pain during treatment.
-
Pregnancy precautions – This medicine can cause birth defects. Female patients who can become pregnant should use effective birth control during treatment and for 1 week after the last dose. Male patients with female partners should also use reliable birth control during treatment and for at least 1 week after stopping.
-
Breastfeeding warning – Do not breastfeed while taking this medicine and for at least 1 week after your last dose.
-
Regular monitoring – Your doctor may recommend lab tests to track how well the therapy is working and to check for side effects.
FAQs about Rahika 200mg Tablet
Q1.
What should I tell my healthcare provider before taking Rahika 200mg tablet?
Inform your physician about all your medical and medication history, including over-the-counter medicines and nutritional or vitamin supplements you are taking.
Q2.
How long do I have to take Rahika 200mg tablet?
The duration of your treatment depends on your disease condition and severity. Your doctor will decide your dose, and duration of your treatment.
Q3.
Can Rahika 200mg tablet given to kidney failure patients?
Yes, Rahika 200mg tablet is safe when prescribed to patients with kidney diseases. No dose adjustments are necessary. Inform your physician if you have any kidney diseases before initiating the treatment.
Q4.
Is Rahika 200mg tablet targeted therapy?
Yes, Rahika 200mg tablet is a targeted therapy. They work by targeting a mutation in MET gene. This helps slow or stop the spread of cancer cells.
Q5.
What if I overdose Rahika 200mg tablet?
If you overdose on the medicine unintentionally or accidentally, seek medical advice immediately. Do not overdose on the medicine.
Fact Box
|
Molecule name: |
Capmatinib |
|
Therapeutic class: |
Anti-cancer |
|
Pharmacological class: |
Protein Kinase Inhibitors |
|
Indications: |
Non-small cell lung cancer (NSCLC) |
References
- Capmatinib Tablets, PIL.; 2022. Accessed May 2, 2023. https://www.ema.europa.eu/en/documents/product-information/tabrecta-epar-product-information_en.pdf
- TABRECTATM - Capmatinib Tablets.; 2020. Accessed May 2, 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213591s000lbl.pdf
- Vansteenkiste JF, Van De Kerkhove C, Wauters E, Van Mol P. Capmatinib for the treatment of non-small cell lung cancer. Expert Review of Anticancer Therapy. 2019;19(8):659-671. doi:https://doi.org/10.1080/14737140.2019.1643239
- Choi W, Park SY, Lee Y, et al. The Clinical Impact of Capmatinib in the Treatment of Advanced Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation or Gene Amplification. Cancer Research and Treatment. Published online January 29, 2021. doi:https://doi.org/10.4143/crt.2020.1331
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Deva Prasath S.
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
